SHELLY SHEARIN: Open Payments
NPI 1659098291 · NORLINA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 24 payments from 11 companies in 2025. Trend: 2023 $739 · 2024 $767 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $119 |
| GlaxoSmithKline, LLC. | 5 | $108 |
| Lilly USA, LLC | 2 | $108 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Gilead Sciences, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $41 |
| Novo Nordisk Inc | 1 | $27 |
| PFIZER INC. | 1 | $19 |
| Viatris Specialty LLC | 1 | $17 |
| Alkermes, Inc. | 1 | $17 |
Products named: Korlym, TRELEGY ELLIPTA, ZEPBOUND, The Cologuard Plus Collection Kit, FARXIGA, Wegovy, BREZTRI, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
